St. Jude Medical Soars To New Heights

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medtech titan St. Jude Medical gets an end-of-the-year boost, setting record highs day after day for nearly a week until peaking at $63.15 the day after Christmas. Medical device giant St. Jude Medical (NYSE:STJ) ended 2013 with a boost, notching a new Wall Street high-water mark of $63.15 on December 26. Shares sank back down to close at $62.74 that day and have since dropped further to close at $61.71 today, but are still trading 4.6% higher than they were 1 month ago and 12.6% higher than 3 months ago.

Help employers find you! Check out all the jobs and post your resume.

Back to news